Log in to save to my catalogue

Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-a...

Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3165ae88e4ee4d8fbc11cdb1b62216c9

Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-analysis of randomized trials

About this item

Full title

Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-analysis of randomized trials

Publisher

England: BioMed Central Ltd

Journal title

BMC cardiovascular disorders, 2017-06, Vol.17 (1), p.150-150, Article 150

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Previous studies suggested that phosphodiesterase 5 inhibitors (PDE5i) have a beneficial effect in patients with heart failure (HF), although the results were inconsistent. We performed a meta-analysis to evaluate the effect of PDE5i in HF patients, and investigated the relationship between PDE5i effects and pulmonary hemodynamics.
We searched P...

Alternative Titles

Full title

Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-analysis of randomized trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3165ae88e4ee4d8fbc11cdb1b62216c9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3165ae88e4ee4d8fbc11cdb1b62216c9

Other Identifiers

ISSN

1471-2261

E-ISSN

1471-2261

DOI

10.1186/s12872-017-0576-4

How to access this item